Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: 60-32-2
Brand: DM
Productivity: 2000kg/month
Transportation: Ocean,Air
Place of Origin: Hebei,China
Supply Ability: 2000kg/month
Certificate: ISO9001
Port: Shanghai
Payment Type: L/C,T/T,Paypal
6-aminocaproic acid (Brand name: Amicar) is a kind of synthetic derivative of lysine. Since it is a analogue of amino acid lysine, it can act as the inhibitor for enzymes that need to bind to that particular lysine residue, e.g. the proteolytic enzyme such as plasmin, which is responsible for fibrinolysis. Therefore, it has anti-fibrinolytic activity. It also competitively inhibits activation of plasminogen, thereby reducing conversion of plasminogen to plasmin. Based on this property, it can be used for the treatment of acute bleeding due to elevated fibrinolytic activity in many clinical situations. It can also indicated by FDA for
the prevention of recurrent hemorrhage in patients of traumatic hyphema. It may also act as a prophylactic against the vascular disease due to its inhibitory effect on the formation of lipoprotein which is the risk factor of vascular disease.
Product Name: | 6-Aminocaproic acid |
Synonyms: | 6-Aminohexanoic acid 60-32-2;Pyrogallol ;6-Aminocaproic acid 60-32-2 6-Aminohexanoic acid;177 J.D;177 J.D.;177j.d.;177jd; 6-amino-hexanoicaci |
CAS: | 60-32-2 |
MF: | C6H13NO2 |
MW: | 131.17 |
EINECS: | 200-469-3 |
Product Categories : APIs And Intermediates > APIs Powder
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.